212 related articles for article (PubMed ID: 28687572)
21. Personalising the treatment of prostate cancer.
Gunjur A
Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591
[No Abstract] [Full Text] [Related]
22. Session 2: Mutational discordance: the big challenge in personalized treatments - any solutions?
Siddiqui M; Chand M; Eng C; Mehdizadeh A; Mirnezami A; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():49-51. PubMed ID: 29878676
[TBL] [Abstract][Full Text] [Related]
23. The forest and the trees: pathways and proteins as colorectal cancer biomarkers.
Bertagnolli MM
J Clin Oncol; 2009 Dec; 27(35):5866-7. PubMed ID: 19884524
[No Abstract] [Full Text] [Related]
24. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
25. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
26. Biomarker-Driven Treatments Yield Better Results.
Cancer Discov; 2016 Aug; 6(8):OF4. PubMed ID: 27357459
[TBL] [Abstract][Full Text] [Related]
27. Paul Workman: Drugging the Cancer Genome.
Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887
[No Abstract] [Full Text] [Related]
28. Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics.
Scher HI; Nasso SF; Rubin EH; Simon R
Clin Cancer Res; 2011 Nov; 17(21):6634-40. PubMed ID: 22046024
[TBL] [Abstract][Full Text] [Related]
29. Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity.
Gandara DR; Li T; Lara PN; Mack PC; Kelly K; Miyamoto S; Goodwin N; Beckett L; Redman MW
Clin Lung Cancer; 2012 Sep; 13(5):321-5. PubMed ID: 22677432
[No Abstract] [Full Text] [Related]
30. Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
Weller M; Wick W; Hegi ME; Stupp R; Tabatabai G
Future Oncol; 2010 Sep; 6(9):1407-14. PubMed ID: 20919826
[TBL] [Abstract][Full Text] [Related]
31. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
32. Editorial comment.
Lotan Y; Merseburger AS
Curr Opin Urol; 2017 Jan; 27(1):34. PubMed ID: 27902674
[No Abstract] [Full Text] [Related]
33. Probabilistic medicine: a pre-emptive approach is needed for cancer therapeutic risk mitigation.
Hicks JK; McLeod HL
Biomark Med; 2019 Aug; 13(12):987-990. PubMed ID: 31385527
[No Abstract] [Full Text] [Related]
34. Next generation sequencing for gynecologic malignancy: Promise and potential pitfalls.
Hinchcliff EM; Westin SN
Gynecol Oncol; 2021 Nov; 163(2):217-219. PubMed ID: 34756289
[No Abstract] [Full Text] [Related]
35. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
36. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
37. Molecular selection trumps clinical selection.
Shepherd FA
J Clin Oncol; 2011 Jul; 29(21):2843-4. PubMed ID: 21670452
[No Abstract] [Full Text] [Related]
38. Treatment strategy for metastatic breast cancer according to intrinsic subtype.
Noguchi S
Int J Clin Oncol; 2010 Aug; 15(4):333-4. PubMed ID: 20632058
[No Abstract] [Full Text] [Related]
39. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
40. Lack of access to targeted cancer therapy.
Burki TK
Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]